title: AP1 factor inactivation in the suprabasal epidermis causes increased epidermal hyperproliferation and hyperkeratosis but reduced carcinogen-dependent tumor formation.
abstract: Activator protein one (AP1) (jun/fos) factors comprise a family of transcriptional regulators (c-jun, junB, junD, c-fos, FosB, Fra-1 and Fra-2) that are key controllers of epidermal keratinocyte survival and differentiation, and are important drivers of cancer development. Understanding the role of these factors in epidermis is complicated by the fact that each member is expressed in defined cell layers during epidermal differentiation, and because AP1 factors regulate competing processes (that is, proliferation, apoptosis and differentiation). We have proposed that AP1 factors function differently in basal versus suprabasal epidermis. To test this, we inactivated suprabasal AP1 factor function in mouse epidermis by targeted expression of dominant-negative c-jun (TAM67), which inactivates function of all AP1 factors. This produces increased basal keratinocyte proliferation, delayed differentiation and extensive hyperkeratosis. These findings contrast with previous studies showing that basal layer AP1 factor inactivation does not perturb resting epidermis. It is interesting that in spite of extensive keratinocyte hyperproliferation, susceptibility to carcinogen-dependent tumor induction is markedly attenuated. These novel observations strongly suggest that AP1 factors have distinct roles in the basal versus suprabasal epidermis, confirm that AP1 factor function is required for normal terminal differentiation, and suggest that AP1 factors have a different role in normal epidermis versus cancer progression.
authors.affiliation: Department of Microbiology and Immunology, University of Maryland School of Medicine, Baltimore, MD 21201, USA. erorke@SOM.umaryland.edu
authors.forename: E A
authors.initials: EA
authors.lastname: Rorke
authors.forename: G
authors.initials: G
authors.lastname: Adhikary
authors.forename: R
authors.initials: R
authors.lastname: Jans
authors.forename: J F
authors.initials: JF
authors.lastname: Crish
authors.forename: R L
authors.initials: RL
authors.lastname: Eckert
mesh_terms: D015127:9,10-Dimethyl-1,2-benzanthracene / Q000633:toxicity; D000818:Animals; D001483:Base Sequence; D002273:Carcinogens / Q000633:toxicity*; D049109:Cell Proliferation; D017931:DNA Primers; D004817:Epidermis / Q000378:metabolism*; D051379:Mice; D008822:Mice, Transgenic; D009374:Neoplasms, Experimental / Q000139:chemically induced / Q000473:pathology*; D016133:Polymerase Chain Reaction; D012871:Skin Diseases / Q000378:metabolism*; D013755:Tetradecanoylphorbol Acetate / Q000633:toxicity; D018808:Transcription Factor AP-1 / Q000378:metabolism*
chemical_list: D002273:Carcinogens; D017931:DNA Primers; D018808:Transcription Factor AP-1; D015127:9,10-Dimethyl-1,2-benzanthracene; D013755:Tetradecanoylphorbol Acetate
references.citation: Physiol Rev. 1989 Oct;69(4):1316-46
references.pmid: 2678169
references.citation: Exp Dermatol. 2005 Jul;14(7):519-27
references.pmid: 15946240
references.citation: J Invest Dermatol. 2006 Feb;126(2):243-57
references.pmid: 16418733
references.citation: Curr Opin Cell Biol. 1997 Apr;9(2):240-6
references.pmid: 9069263
references.citation: Oncogene. 1994 Mar;9(3):791-9
references.pmid: 8108121
references.citation: Epithelial Cell Biol. 1994 Jul;3(3):96-101
references.pmid: 7534576
references.citation: Photodermatol. 1987 Jun;4(3):127-34
references.pmid: 3317295
references.citation: Cancer Res. 1985 Nov;45(11 Pt 2):5845-50
references.pmid: 2414001
references.citation: Vet Clin North Am Equine Pract. 2004 Aug;20(2):319-43, vi
references.pmid: 15271426
references.citation: Mol Carcinog. 2002 Jun;34(2):72-7
references.pmid: 12112313
references.citation: Invest Ophthalmol Vis Sci. 2004 Apr;45(4):1080-7
references.pmid: 15037572
references.citation: J Biol Chem. 1995 May 26;270(21):12614-22
references.pmid: 7759510
references.citation: Expert Opin Investig Drugs. 1999 Apr;8(4):393-401
references.pmid: 15992087
references.citation: Exp Gerontol. 2000 Feb;35(1):53-62
references.pmid: 10705039
references.citation: Exp Dermatol. 1999 Feb;8(1):71-9
references.pmid: 10206724
references.citation: Oncogene. 1995 Dec 21;11(12):2681-7
references.pmid: 8545126
references.citation: Oncogene. 2002 Jan 24;21(5):738-47
references.pmid: 11850802
references.citation: J Invest Dermatol. 2004 Jul;123(1):13-22
references.pmid: 15191537
references.citation: J Invest Dermatol. 2003 May;120(5):823-8
references.pmid: 12713588
references.citation: Invest Ophthalmol Vis Sci. 1993 Nov;34(12):3429-41
references.pmid: 7693609
references.citation: Differentiation. 1994 Sep;57(3):187-93
references.pmid: 7527355
references.citation: J Biol Chem. 1995 Jul 14;270(28):16483-6
references.pmid: 7622446
references.citation: Differentiation. 1993 Jul;53(3):191-200
references.pmid: 8405770
references.citation: Mol Cancer Res. 2003 Sep;1(11):848-54
references.pmid: 14517347
references.citation: Proc Natl Acad Sci U S A. 1989 Apr;86(7):2257-61
references.pmid: 2648396
references.citation: Cancer Res. 2002 Jun 1;62(11):3044-7
references.pmid: 12036911
references.citation: EMBO J. 2000 Jun 15;19(12):2969-79
references.pmid: 10856241
references.citation: J Investig Dermatol Symp Proc. 2002 Dec;7(1):27-35
references.pmid: 12518789
references.citation: J Invest Dermatol. 2008 Mar;128(3):530-41
references.pmid: 17882273
references.citation: J Biol Chem. 1998 Sep 18;273(38):24387-95
references.pmid: 9733728
references.citation: J Clin Invest. 2001 Oct;108(7):991-9
references.pmid: 11581300
references.citation: Ann N Y Acad Sci. 1998 Jun 30;851:139-46
references.pmid: 9668616
references.citation: J Invest Dermatol. 2006 Apr;126(4):902-11
references.pmid: 16439969
references.citation: Mol Carcinog. 2006 Jan;45(1):1-9
references.pmid: 16302268
references.citation: J Investig Dermatol Symp Proc. 2002 Dec;7(1):36-40
references.pmid: 12518790
references.citation: J Biol Chem. 2002 Aug 30;277(35):31753-60
references.pmid: 12080077
references.citation: Nat Genet. 2002 Feb;30(2):158-66
references.pmid: 11818961
references.citation: Development. 2000 Nov;127(22):4937-48
references.pmid: 11044407
references.citation: J Invest Dermatol. 2006 Feb;126(2):305-14
references.pmid: 16374477
references.citation: Physiol Rev. 1997 Apr;77(2):397-424
references.pmid: 9114819
references.citation: Cancer Res. 2002 Mar 1;62(5):1343-8
references.pmid: 11888903
references.citation: Proc Natl Acad Sci U S A. 1999 Aug 17;96(17):9827-32
references.pmid: 10449779
references.citation: J Invest Dermatol. 1983 Jul;81(1 Suppl):109s-15s
references.pmid: 6190956
references.citation: Nature. 2005 Sep 15;437(7057):369-75
references.pmid: 16163348
references.citation: J Biol Chem. 2003 Sep 5;278(36):34277-85
references.pmid: 12810719
references.citation: Cancer Res. 1987 Sep 1;47(17):4674-80
references.pmid: 2441853
references.citation: Adv Dermatol. 2000;16:159-83; discussion 184
references.pmid: 11094627
references.citation: EMBO J. 2000 May 2;19(9):2056-68
references.pmid: 10790372
references.citation: Genes Dev. 2000 Nov 1;14(21):2695-700
references.pmid: 11069886
references.citation: Cell. 1985 Mar;40(3):677-83
references.pmid: 2578890
references.citation: Nat Cell Biol. 2002 May;4(5):E131-6
references.pmid: 11988758
references.citation: Oncogene. 2001 Apr 30;20(19):2390-400
references.pmid: 11402335
references.citation: Mol Biol Rep. 1996;23(1):59-70
references.pmid: 8983019
references.citation: J Dermatol Sci. 2002 Nov;30(2):94-9
references.pmid: 12413764
references.citation: Biochem J. 1998 Apr 1;331 ( Pt 1):61-8
references.pmid: 9512462
references.citation: Exp Dermatol. 2001 Feb;10(1):45-54
references.pmid: 11168579
references.citation: J Dermatol. 2004 Apr;31(4):271-6
references.pmid: 15187321
references.citation: J Biol Chem. 1998 Nov 13;273(46):30460-5
references.pmid: 9804813
references.citation: J Invest Dermatol. 2000 Nov;115(5):788-94
references.pmid: 11069615
references.citation: Mol Cell Biol. 2004 Sep;24(18):8167-83
references.pmid: 15340077
references.citation: Cell Death Differ. 1996 Oct;3(4):373-83
references.pmid: 17180107
references.citation: J Invest Dermatol. 2004 Aug;123(2):313-8
references.pmid: 15245431
references.citation: Cancer Res. 2007 Mar 15;67(6):2430-8
references.pmid: 17363560
references.citation: J Invest Dermatol. 2001 Jul;117(1):1-2
references.pmid: 11442743
references.citation: Cancer Res. 2000 Nov 15;60(22):6332-8
references.pmid: 11103794
references.citation: J Invest Dermatol. 2005 Jan;124(1):212-20
references.pmid: 15654976
references.citation: Oncogene. 2001 Apr 30;20(19):2413-23
references.pmid: 11402337
references.citation: Cell. 1995 Sep 8;82(5):721-32
references.pmid: 7545543
references.citation: Genes Dev. 1993 Mar;7(3):479-90
references.pmid: 8383624